SchmittW.H., CsernokE., FleschB.K.Autoantibodies against lysozyme: a new target antigen for antineutrophil cytoplasm antibodies (ANCA). Proceedings of 4th ANCA International Workshop; 1992 May; Lubeck.
2.
Cohen-TervaertJ.W., HuitemaM.G., DolmanK.M.Clinical significance of autoantibodies to human leucocyte elastase.Br J Rheumatol (in press).
3.
LesavreP., ChenN., NusbaumP. Antineutrophil cytoplasmic antibodies (ANCA) with anti-lactoferrin activity in vasculitis.Kidney Int1990; 37: 442.
4.
FalkR.J., JennetteJ.C.Antineutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescent glomerulonephritis.N Engl J Med1988; 318: 1651–7.
5.
Van der WoudeF.J., van DahamresL.A.Review: the current status of neutrophil cytoplasmic antibodies.Clin Exp Immunol1989; 78: 143–9.
6.
HauschildS., SchmittW.H., CsernokE.ANCA in Wegener granulomatosis and related vasculitides. Proceedings of 4th ANCA International Workshop; 1992 May; Lubeck.
7.
GaskinG., TurnerA.N., RyanJ.J.Significance of autoantibodies to purified proteinase 3 in systemic vasculitis. Proceedings of 4th ANCA International Workshop; 1992 May; Lubeck.
8.
DahaM.R., FalkR.J.Antimyeloperoxidase antibodies and clinical associations.Netherlands J Med1990; 36: 152–3.
9.
Comm.Third International Workshop on ANCA, Washington, Nov 29-30, 1990.
10.
JenetteJ.C., FalkR.J.Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.Am J Kidney Dis1990; 6: 517–29.
